Johnson Fistel Begins Investigation into Cardlytics Following a Significant Drop in the Company's Stock

Core Insights - Johnson Fistel, LLP is investigating potential violations of securities laws by Cardlytics, Inc. and its executives regarding misrepresentation or failure to disclose adverse information to investors [1][3] - Cardlytics reported a 9% year-over-year decrease in revenue to $69.6 million and a 3% decline in adjusted contribution to $36.4 million for Q2 2024 [3] - Following the financial results announcement, Cardlytics' stock dropped 56% in pre-market trading on August 8, 2024 [3] Investigation Details - The investigation focuses on the losses suffered by investors and the possibility of recovering those losses under federal securities laws [1][3] - Individuals with nonpublic information about Cardlytics are encouraged to assist in the investigation or consider the SEC Whistleblower program, which may offer rewards for original information leading to successful recovery [4] Company Background - Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, and Colorado, representing individual and institutional investors in securities class action lawsuits [5]